ReviewTrends in cardiovascular medicine2009

P2X(1) receptor inhibition and soluble CD39 administration as novel approaches to widen the cardiovascular therapeutic window.

C Y E Fung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.